keith harding frcgp frcp frcs - wounds uk tv · pdf filea welsh wound initiative keith harding...

“Health & Wealth for Wales”

THE CREATION OF A WELSH WOUND INITIATIVEKeith Harding FRCGP FRCP FRCS

Sub Dean of Innovation & Engagement School of Medicine

Head of Section of Wound Healing Clinical Lead Wound Healing Cardiff & Vale LHB


History of Wounds

- No one interested

- No one in charge

- No professionalism

- No investment

- No recognition, acceptance

- No legitimacy


Current Situation in UK

•

If wound healing problems account for 5%

health care spend –why

does the subject not have a high profile ?

•

Wound problems exist in all aspects of clinical practice but there is no consistency or standardisation of approach to care


Resource Utilisation•

In a typical acute hospital, between 25% and 40%

of beds are occupied by patients

with a wound

•

In the community 25-75%

of nurse time is spent on wound related care, with 70%

of

all wounds being treated in this setting

•

Demographic changes will increase the demand for wound care at a time when nursing and hospital resources are likely to be increasingly scarce


Pressure ulcers•

A recent EPUAP study of 25 hospitals in 5 European countries found prevalence of pressure ulcers of 20% -

in the UK, the

rate was 22% PEPUS Study

•

This means around 1 in 5 hospital beds is occupied by a patient with a pressure ulcer

•

Typically, 60%-80% of these pressure ulcers are hospital-acquired

•

Between 30%-35% of pressure ulcers are at Stage 3 or above


•

9%

of hospital inpatients at any one time will acquire an infection during their stay

•

There are at least 100,000

HAI a year

•

5,000

deaths a year

•

Financial impact1. Auditor General (2000) the management and control of Hospital Acquired Infection in

Acute NHS in England.2. DOH CMO (England) (2002) Getting ahead of the curve

1

1

2

The Impact of Healthcare Associated Infection (HCAI)


Surgical wound infection•

A typical hospital carrying out

13,500 at-risk operations annually can expect 525-650 surgical infections, at a cost of £2m

and

5,200

excess bed-days•

Increased LOS = 9 days

•

Reducing the rate of infection by just 10% could release £200k and 500+ bed-days


Are the research questions always focused in the right area?

Materials: Typically 10%-

15% of total cost

Nurse Time: Typically 25%-

30% of total cost

Hospitalisation: Typically 50%+ of total cost


Wound Healing in Cardiff University•

Dept of Wound Healing, is a self funded group which has existed for over 18 years.

•

Many of its staff have significant International profiles and the reputation of the Dept places it as one of the top wound research units within the world.

•

How does the Department continue to grow, innovate and excel globally?


Mission Statement 1991

The Wound Healing Research Unit will provide and continue to develop a world class clinical, scientific and educational wound healing resource for the long term benefit of patients with wound problems.

Price and Harding 1997, 2004

•

Cardiff Wound Impact Schedule: chronic wounds of lower leg

•

3 domains (experience and related stressfulness)

•

Validated against SF-36

•

Standard psychometrics assessed

•

Sensitive to healing status

HRQoL

in Chronic Leg Ulcers

Medical Recognition of Importance of Wounds-2006

Number of Students who have graduated with an Exit Award*: July 1998 –

Aug 2010

*PG Cert Exit award introduced in 2004

10088

15

0

20

40

60

80

100

No of awards

PG DipMScPG Cert


Academic Outputs & Self Sufficiency in Cardiff

•

1075 Publications 1975-2009•

42 Grants & £10 million funding obtained

•

178 Clinical Studies Undertaken•

44 Companies linked & £20 million obtained

•

28 MDs/PhDs•

National, European and International Societies.

•

CITER, ffenics, Welsh Wound Network


The Dept. of Wound Healing

• Directorate of Wound Healing Cardiff & Vale

• MDT Model DFU Gwent

• Community Wound Clinics Cardiff

• Wide referral practice

• Largest Managed Bed Contract in Europe

• HSJ Prize Partnership with Industry 2003

• Innovation Partnership:

NHS + Welsh SME +CU = Product (Repose)

Clinical Innovation -2010

The Cardiff Team•

Medical 38

•

Including-Les Hughes, Joe Marks, David Leaper, David Armstrong

, Girish

Patel ,Joe Grey, Surgical Research Fellows

•

Nursing/Clinical 43•

Including-Nicky Ivins, Wendy Davies, Sue Bale, Sue Hagelstein, Christine Moffatt, Heather Orsted

•

Research 36 •

Including-Tricia Price, Mike Clark, Chris Lawrence, Keith Moore, Liz Mudge

•

Education 7•

Including-

Sam

Holloway, Vanessa Jones, Jacqui Fletcher, Julie Boyd•

Admin 11

•

Including-Rachel Davey, Susan Taylor, Jane Hopkins


Wounds in Cardiff

CARDIFF UNIVERSITY

COMMERCIAL

RESEARCH CLINICAL


Wounds in Wales -

Current

CARDIFF UNIVERSITY

MEDIWALES

WELSH WOUND NETWORKGLAMORGAN

UNIVERSITY

SWANSEA UNIVERSITY

BANGOR UNIVERSITY

COMMERCIAL ENTITIES

NATIONAL HEALTH SERVICE(TVNs)

SMTLGLYNDWR UNIVERSITY

COMMERCIAL

RESEARCH CLINICAL

UWIC


Wounds in Wales –

Key Facts•

Wound healing employs around 2500 people in Wales

•

With approximately a further 100 academic researchers and full-time specialist nurses

•

Commercial turnover in excess of £70 million annually

•

These incomes should be set in the context of the total spend on wound healing in Wales which is likely to be around £156 million annually.

Source -

MediWales


Wounds in Wales -

Current

CARDIFF UNIVERSITY

MEDIWALES


UNIVERSITY

SWANSEA UNIVERSITY

BANGOR UNIVERSITY

COMMERCIAL ENTITIES



COMMERCIAL

RESEARCH CLINICAL

UWIC


Wounds in Wales -

Future

MEDIWALES


UNIVERSITY

SWANSEA UNIVERSITY

BANGOR UNIVERSITY

COMMERCIAL ENTITIES



COMMERCIAL

RESEARCH CLINICAL

UWIC

WELSH WOUND INNOVATION CENTRE

CARDIFFUNIVERSITY


Continued Evolution of A New Clinical Specialty

•

The creation of an initiative which aids the continued development of wound care as a clinical specialty.

•

Through this initiative creating a centre of excellence and core competence for Wales.

•

Ensuring enough profile and critical mass to be the ‘centre’

of choice.

•

Establish a core competence of expertise at the leading edge of the development of this clinical specialty.

CARDIFF

STAKEHOLDERS

EXISTING COMPANIES AND ROUTE TO MARKET

WELSH HIGHER

EDUCATION

INSTITUTES

WELSH

NATIONAL

HEALTH

SERVICE

CARDIFF & VALE

GWENT

SWANSEA

OTHER WELSH

BURNS INITIATIVEGLAMORGAN

CARDIFF

SWANSEA

BANGOR

OTHERS

UNI OF WALES

CONVATEC

FRONTIER

ARJO

HUNTLEIGH

ZOOBIOTIC

SMTLWELSH

WOUND

NETWORK

STAKEHOLDERS


ECONOMIC DIVISION

MINISTERS NHSWORD

WELSH HIGHER

EDUCATION

INSTITUTES

WELSH

NATIONAL

HEALTH

SERVICE

WELSH

ASSEMBLY

GOVERNMENT

CARDIFF & VALE

GWENT

SWANSEA

OTHER WELSH

BURNS INITIATIVEGLAMORGAN

CARDIFF

SWANSEA

BANGOR

OTHERS

UNI OF WALES

CONVATEC

FRONTIER

ARJO

HUNTLEIGH

ZOOBIOTIC

MEDIWALES

SMTLWELSH

WOUND

NETWORK

STAKEHOLDERS


ECONOMIC DIVISION

MINISTERS NHSWORD

WELSH HIGHER

EDUCATION

INSTITUTES

WELSH

NATIONAL

HEALTH

SERVICE

WELSH

ASSEMBLY

GOVERNMENT

CARDIFF & VALE

GWENT

SWANSEA

OTHER WELSH

BURNS INITIATIVE

OTHER NON WELSH

(e.g. HULL, LONDON)

GLAMORGAN

CARDIFF

SWANSEA

BANGOR

OTHERS

UNI OF WALES

CONVATEC

FRONTIER

ARJO

HUNTLEIGH

ZOOBIOTIC

SMITH & NEPHEW

3M HEALTHCARE

NITRIC BIO

ADVANCED BIOHEALING

KCI

SYSTAGENIX

COVIDIEN

BBRAUN

INSENSE LTD

MOLNLYCKE COLOPLAST

HILL ROM

LINDE

PHOTOPHARMICA

MEDIWALES

SMTLWELSH

WOUND

NETWORK

WELSH WOUND

INNOVATION

CENTRE

STAKEHOLDERS


ECONOMIC DIVISION

MINISTERS NHSWORD

WELSH HIGHER

EDUCATION

INSTITUTES

WELSH

NATIONAL

HEALTH

SERVICE

WELSH

ASSEMBLY

GOVERNMENT

CARDIFF & VALE

GWENT

SWANSEA

OTHER WELSH

BURNS INITIATIVE

OTHER NON WELSH

(e.g. HULL, LONDON)

GLAMORGAN

CARDIFF

SWANSEA

BANGOR

OTHERS

UNI OF WALES

CONVATEC

FRONTIER

ARJO

HUNTLEIGH

ZOOBIOTIC

SMITH & NEPHEW

3M HEALTHCARE

NITRIC BIO

ADVANCED BIOHEALING

KCI

SYSTAGENIX

COVIDIEN

BBRAUN

INSENSE LTD

MOLNLYCKE COLOPLAST

HILL ROM

LINDE

PHOTOPHARMICA

PREVENTION

ACUTE CHRONIC

SKIN HEALTH

MEDIWALES

SMTLWELSH

WOUND

NETWORK

WELSH WOUND

INNOVATION

CENTRE

START UP

COMPANIES OR

NEW DIVISIONS

STAKEHOLDERS

SME RELOCATION OR EXPANSION


ECONOMIC DIVISION

MINISTERS NHSWORD

WELSH HIGHER

EDUCATION

INSTITUTES

WELSH

NATIONAL

HEALTH

SERVICE

WELSH

ASSEMBLY

GOVERNMENT

CARDIFF & VALE

GWENT

SWANSEA

OTHER WELSH

BURNS INITIATIVE

OTHER NON WELSH

(e.g. HULL, LONDON)

GLAMORGAN

CARDIFF

SWANSEA

BANGOR

OTHERS

UNI OF WALES

MEDX LIGHT

THERAPY

CONVATEC

MOLOGIC LTD

DENDRITE

WOUND CARE

RIMON

THERAPUETICS INC

TISSUE THERAPIES LTD

FRONTIER

ARJO

HUNTLEIGH

PFIZER

AQUAHEAL

BAYER

THERADEV LTD

WOUND GENETICS LTD

ZOOBIOTIC

SMITH & NEPHEW

3M HEALTHCARE

NITRIC BIO

ADVANCED BIOHEALING

KCI

SYSTAGENIX

COVIDIENGSK

BBRAUN

INSENSE LTD

MOLNLYCKE COLOPLAST

HILL ROM

ASTRA ZENECA

LINDE

PHOTOPHARMICA

PREVENTION

ACUTE CHRONIC

SKIN HEALTH

MEDIWALES

SMTLWELSH

WOUND

NETWORK


Welsh Established –

Welsh Driven - Internationally Recognised

•

NHS of Wales would be part of this initiative driving standardisation

of wound practice across Wales.

•

Other Welsh HEIs

have expressed interest in the concept and being involved.

•

Industry has also expressed interest in being part of this initiative locating facilities within the Science Park.

•

Further Welsh based companies have been identified as the first route to market for the many products that could emerge from the multiple organisations.

•

This would strengthen the opportunity of the output of the WWISP obtaining larger global deals with major International companies, as the concepts would not only be clinically and scientifically validated but also test marketed.


BENEFITS OF THE WELSH WOUND INNOVATION CENTRE (WWIC)

AcademicPatient driven researchPatient driven educationWales research focusNational Co‐ordination of effort

ClinicalNHS DrivenStandardisation, Evidence

BasedClinical leadershipEvidence Based Care/Protocols

EconomicCost‐efficient careInward investment to WalesLeverage of research spendClinical excellence training

PoliticalUnified national servicesNational standardsGovernment supported

healthcare innovationInternational model of care


BENEFITS OF THE WELSH WOUND INNOVATION SCIENCE PARK (WWISP)

AcademicResearch/Technology HubCentre of Excellence (World

First!)Grant/Funding AbilityInternational Leadership

ClinicalModel of integrated care and

researchPatient focused technology

developmentSpecialty developmentEarly technology access for

Welsh patientsEconomic“Health & Wealth”

for Wales

Inward InvestmentJob CreationTechnology

Development/Leadership

PoliticalWelsh initiative‐

Welsh Lead –

World First!Welsh competenceBiomedical Innovation leadershipInternational exposure


Next Steps

•

Phase 1 -

Full business plan will be established and funding sources confirmed. √

•

Phase 2 –

Secure Academic, Clinical and Commercial buy-in to the business case and plan. √

•

Phase 3 –

Secure funding. √

Partial••

Phase 4 –

Launch the initiative 2011.


Thank You for Your Attention!

Diolch

i chi am eich gwrandawiad!

Contact –

[email protected]

keith harding frcgp frcp frcs - wounds uk tv · pdf filea welsh wound initiative keith harding...

Documents